clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Removing Notch Ligand, Jagged2, Rewires the Immune System to Eliminate NSCLC
News & Features
Day One’s Targeted Treatment for Most Common Kid’s Brain Tumor Approved
News & Features
UCSF Launches Clinical Trial on New CAR T Therapy for Glioblastoma
News & Features
Aspirin Enhances Colon Cancer Immunosurveillance
News & Features
CAR T-Cell Therapy for Sarcoma Shows Early Promise
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Home
Authors
Posts by Kate Marusina, Ph.D.
Kate Marusina, Ph.D.
4 POSTS
0 COMMENTS
Ph.D.
Molecular Dx
Teasing Out Circulating Tumor DNA
February 8, 2018
News & Features
Paving the Road for Clinical Biomarkers
May 3, 2016
Molecular Dx
Genomic Singularity Is Near
November 19, 2014
Molecular Dx
NGS Ready for Clinical Oncology Testing
August 13, 2014
Related Content
Functional Precision Medicine Leads to Better Cancer Treatments
Cullinan Nets $280M Investment and Targets CD19 in Lupus
Genialis Uses Machine Learning to Personalize Cancer Treatment Outcomes
Liquid Biopsy: A New Frontier in Small-Cell Lung Cancer Management
Inside Precision Medicine
